Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival. (2026). Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026048. https://doi.org/10.4084/MJHID.2026.048